-
公开(公告)号:US20090017055A1
公开(公告)日:2009-01-15
申请号:US12088065
申请日:2006-09-29
申请人: Patrick Duffy , Stefan H. I. Kappe , Urszula Krzych , Donald G. Heppner, JR. , Lawrence W. Bergman , Vladislav A. Malkov , Alice Tarun , Jason W. Wendler , Igor Bacik
发明人: Patrick Duffy , Stefan H. I. Kappe , Urszula Krzych , Donald G. Heppner, JR. , Lawrence W. Bergman , Vladislav A. Malkov , Alice Tarun , Jason W. Wendler , Igor Bacik
IPC分类号: A61K39/015 , C07K14/445 , C07H21/00 , A61P33/06
CPC分类号: C07K14/445 , A61K39/00 , Y02A50/412
摘要: The invention provides isolated liver stage Plasmodium polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-48 and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the liver stage Plasmodium polypeptides of the invention, compositions comprising one or more liver stage Plasmodium polypeptides of the invention, methods for inducing an immune response against the liver stage Plasmodium polypeptides, and methods for treating and diagnosing liver stage malaria.
摘要翻译: 本发明提供了分离的肝阶段疟原虫多肽,其包含选自SEQ ID NO:1-48的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的肝阶段疟原虫多肽的分离的核酸分子,包含本发明的一种或多种肝阶段疟原虫多肽的组合物,诱导针对肝阶段的疟原虫多肽的免疫应答的方法,以及治疗和诊断方法 肝阶段疟疾。
-
公开(公告)号:US07722889B2
公开(公告)日:2010-05-25
申请号:US12088065
申请日:2006-09-29
申请人: Patrick Duffy , Urszula Krzych , Donald G. Heppner, Jr. , Vladislav A. Malkov , Jason W. Wendler , Igor Bacik
发明人: Patrick Duffy , Urszula Krzych , Donald G. Heppner, Jr. , Vladislav A. Malkov , Jason W. Wendler , Igor Bacik
IPC分类号: A61K39/015 , C07K14/445 , C07H21/04 , C12P21/04
CPC分类号: C07K14/445 , A61K39/00 , Y02A50/412
摘要: The invention provides isolated liver stage Plasmodium polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1-48 and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the liver stage Plasmodium polypeptides of the invention, compositions comprising one or more liver stage Plasmodium polypeptides of the invention, methods for inducing an immune response against the liver stage Plasmodium polypeptides, and methods for treating and diagnosing liver stage malaria.
摘要翻译: 本发明提供了分离的肝阶段疟原虫多肽,其包含选自SEQ ID NO:1-48的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的肝阶段疟原虫多肽的分离的核酸分子,包含本发明的一种或多种肝阶段疟原虫多肽的组合物,诱导针对肝阶段的疟原虫多肽的免疫应答的方法,以及治疗和诊断方法 肝阶段疟疾。
-
公开(公告)号:US20100166794A1
公开(公告)日:2010-07-01
申请号:US12722439
申请日:2010-03-11
申请人: Patrick Duffy , Stefan H.I. Kappe , Urszula Krzych , Donald G. Heppner, JR. , Lawrence W. Bergman , Vladislav A. Malkov , Alice Tarun , Jason W. Wendler , Igor Bacik
发明人: Patrick Duffy , Stefan H.I. Kappe , Urszula Krzych , Donald G. Heppner, JR. , Lawrence W. Bergman , Vladislav A. Malkov , Alice Tarun , Jason W. Wendler , Igor Bacik
IPC分类号: A61K39/002 , C07K14/445 , C07H21/04 , A61P33/06
CPC分类号: C07K14/445 , A61K39/00 , Y02A50/412
摘要: The invention provides isolated liver stage Plasmodium polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-48 and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the liver stage Plasmodium polypeptides of the invention, compositions comprising one or more liver stage Plasmodium polypeptides of the invention, methods for inducing an immune response against the liver stage Plasmodium polypeptides, and methods for treating and diagnosing liver stage malaria.
摘要翻译: 本发明提供了分离的肝阶段疟原虫多肽,其包含选自SEQ ID NO:1-48的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的肝阶段疟原虫多肽的分离的核酸分子,包含本发明的一种或多种肝阶段疟原虫多肽的组合物,诱导针对肝阶段的疟原虫多肽的免疫应答的方法,以及治疗和诊断方法 肝阶段疟疾。
-
-